PI3K/AKT/mTOR pathway
The PI3K/AKT/mTOR pathway is a central intracellular signaling cascade that regulates cell growth, survival, metabolism, protein synthesis, autophagy, and stress responses.
The PI3K/AKT/mTOR pathway is a central intracellular signaling cascade that regulates cell growth, survival, metabolism, protein synthesis, autophagy, and stress responses. It is commonly activated by upstream growth factors and other extracellular cues, leading to sequential signaling through phosphoinositide 3-kinase (Phosphatidylinositol 3-kinase (PI3K)), Protein kinase B (PKB), and mechanistic target of rapamycin (Mtor). Because of its broad control over proliferation and survival, dysregulation of this pathway is implicated in cancer, inflammatory disease, aging-related decline, and other disorders.
In biomedical research, the PI3K/AKT/mTOR pathway is frequently studied as both a mechanistic node and a therapeutic target. Its activity is often interpreted alongside related regulators such as PTEN, Protein kinase B (PKB), PRKAA1/AMPK, Sirtuin 1 (SIRT1), MAPK signaling pathway, and Yes-associated protein 1 (YAP1), reflecting its integration with other growth and stress-response networks. Pharmacologic modulation of this pathway is also relevant to agents such as everolimus and sirolimus, which are used as pathway-directed comparators or interventions in translational studies.
Where the papers sit
9 papers from the last 6 months study PI3K/AKT/mTOR pathway directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 5 preclinical · 4 unclassified
Themes one subject
Those 9 are all about one subject.
-
Cross-Disease Signaling Research
Pharmacologic and natural-product modulation of growth, injury, fibrosis, and tissue repair appears across unrelated disease contexts. Studies combine computational prediction, multi-omics, and experimental validation to nominate pathway-targeting compounds and combinations. Reported effects include reduced tumor growth or metastasis, protection from metabolic injury, and improved wound healing. The papers do not support a single disease-specific direction or shared mechanism beyond signaling-pathway involvement.
Papers
The 9 papers from the last 6 months that study PI3K/AKT/mTOR pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Cross-Disease Signaling Research (9)
- From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. PloS one · 16 Sept 2026 PMID 42748134
- Alpinia Oxyphylla-Shenqi Siwu Decoction protects against high glucose-induced retinal pigment epithelial cell injury involving the PI3K/AKT/mTOR pathway. International ophthalmology · 10 Sept 2026 PMID 42720704
- MXRA5 promotes the progression and metastasis of breast cancer via activation of the epithelial-to-mesenchymal transition pathway. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 27 Aug 2026 PMID 42657493
- Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 18 Aug 2026 PMID 42610529
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- Synergistic inhibition of the PI3K-AKT-mTOR signaling pathway in idiopathic pulmonary fibrosis by Sanleng-Ezhu: a multi-omics and experimental study. Functional & integrative genomics · 26 Jun 2026 PMID 42362788
- Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
- High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation. Scientific reports · 6 Jun 2026 PMID 42251134
- Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced biology · 30 May 2026 PMID 42216572
By study type
Preclinical: animal, cell and lab studies (5)
- From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. PloS one · 16 Sept 2026 PMID 42748134
- Alpinia Oxyphylla-Shenqi Siwu Decoction protects against high glucose-induced retinal pigment epithelial cell injury involving the PI3K/AKT/mTOR pathway. International ophthalmology · 10 Sept 2026 PMID 42720704
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- Antitumor effect of the AP5Z1 small-molecule inhibitor PGG in hepatocellular carcinoma. Medical oncology (Northwood, London, England) · 25 Jun 2026 PMID 42347921
- Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma. Advanced biology · 30 May 2026 PMID 42216572
Unclassified: not yet indexed with MeSH (4)
- MXRA5 promotes the progression and metastasis of breast cancer via activation of the epithelial-to-mesenchymal transition pathway. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 27 Aug 2026 PMID 42657493
- Loss of LCN2 Function Ameliorates Glucocorticoid-Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 18 Aug 2026 PMID 42610529
- Synergistic inhibition of the PI3K-AKT-mTOR signaling pathway in idiopathic pulmonary fibrosis by Sanleng-Ezhu: a multi-omics and experimental study. Functional & integrative genomics · 26 Jun 2026 PMID 42362788
- High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation. Scientific reports · 6 Jun 2026 PMID 42251134
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-07-02. Last written: 2026-09-18 by GPT. Drafted by language models from published abstracts; not medical advice.